Moderna Stock Drops on Plans To Cut $1.1B in R&D Costs - Yahoo …

Sep 12, 2024 · Moderna shares fell Thursday morning as the COVID vaccine maker said it plans to cut R&D spending by $1.1 billion over the next three years.

$1
OFF

Moderna Stock Drops On Plans To Cut $1.1B In R&D Costs - Yahoo …

2 weeks from now

Sep 12, 2024 · Moderna shares fell Thursday morning as the COVID vaccine maker said it plans to cut R&D spending by $1.1 billion over the next three years.

yahoo.com

20%
OFF

Moderna Stock Plunges Nearly 20% As Company Reports Poor …

2 weeks from now

Sep 12, 2024 · The Cambridge-based biotech and pharmaceutical company announced it will discontinue five research and development programs in order to cut $1.1 billion from its annual …

yahoo.com

$1
OFF

Moderna Faces Analyst Downgrades Amid Revised R&D …

2 weeks from now

Sep 13, 2024 · Thursday, Moderna Inc (NASDAQ:MRNA) unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, enabling a focus on ten …

yahoo.com

$1
OFF

Moderna Targets $1.1B In R&D Spending Cuts, Drops 5 Programs …

2 weeks from now

Sep 12, 2024 · Cutting the budget will take time, with Moderna forecasting R&D spending of $4.2 billion to $4.5 billion in 2025. The biotech disclosed a raft of pipeline changes as part of the …

fiercebiotech.com

$1
OFF

Moderna Surprises The Street By Predicting A Bigger-than …

2 weeks from now

2 days ago · The company also said it was speeding up and expanding a cost-cutting plan. It expects to cut cash costs by $1 billion in the new year, with additional cuts planned in 2026. …

apnews.com

$1
OFF

Moderna Will Cut $1.1bn Off Its Annual R&D Spend

2 weeks from now

4 days ago · Moderna said the changes will reduce the cumulative spend on R&D between 2025 and 2028 to $16 billion from $20 billion, and allow it to break even financially in 2028.

pharmaphorum.com

$1
OFF

Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut

2 weeks from now

Sep 13, 2024 · Shares of Moderna fell Friday after taking on steep losses a day earlier on the news that it plans to cut research and development spending by $1.1 billion by 2027.

investopedia.com

$1
OFF

Moderna Shares Plunge On Plans To Cut $1.1 Billion In Costs ... - MSN

2 weeks from now

Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its …

msn.com

20%
OFF

StockWatch: Moderna's $1.1B R&D Cut, Profitability Delay Jolt …

2 weeks from now

Sep 16, 2024 · Over the next three years, Moderna added, it will cut about between $1 billion and $1.2 billion in expenses by shrinking its R&D budget by about 20%, going from the $4.8 billion …

genengnews.com

20%
OFF

Moderna To Cut Costs, Trim Pipeline In R&D Revamp

2 weeks from now

Sep 12, 2024 · Dive Brief: Moderna will cut R&D spending by 20% and trim its pipeline as part of a strategic overhaul that will shift its research focus and put more resources into products that …

biopharmadive.com

$1
OFF

Moderna Targets $1.1B In R&D Spending Cuts, Drops 5 Programs …

2 weeks from now

Dec 19, 2024 · The headline change is the reduction in R&D spending, which the biotech wants to get down to $3.6 billion to $3.8 billion in 2027. Moderna aims to generate the savings through …

biotech-insider.com

$1
OFF

Moderna Shares Plunge After Cutting Research Budget

2 weeks from now

Sep 12, 2024 · The drugmaker revealed at its annual R&D Day that it plans to reduce its R&D expenses by approximately $1.1 billion, lowering projected costs from $4.8 billion in 2024 to …

investing.com

$1
OFF

Moderna To Slash Costs By $1.1B - LinkedIn

2 weeks from now

Sep 12, 2024 · Moderna, the biotech company known for developing one of the COVID-19 vaccines, plans to cut $1.1 billion in expenses by 2027 as it adjusts its business in the post …

linkedin.com

1%
OFF

Moderna Stock Plummets On Cost-Cutting Measures

2 weeks from now

Sep 12, 2024 · The stock has continued to move lower since its 21.1% post-earnings drop on August 1, and is currently down 35.4% year to date. Options traders are chiming in on the drop.

schaeffersresearch.com

17%
OFF

Watch These Moderna Price Levels As Stock Plummets After

2 weeks from now

1 day ago · Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its 2025 revenue forecast by $1 billion. Watch these crucial …

investopedia.com

$1
OFF

Moderna Slashes Sales Forecast By $1B, Eyes FDA ... - Yahoo Finance

2 weeks from now

2 days ago · CEO Stephane Bancel said Moderna plans to cut 2025 cash costs by $1 billion, with another $500 million in reductions targeted for 2026. The company anticipates finishing 2025 …

yahoo.com

17%
OFF

Moderna Stock Plunges Nearly 17% After Company Lowers 2025 …

2 weeks from now

Moderna lowered its 2025 sales guidance by roughly $1 billion, as it continues to cut costs. The biotech company now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, …

msn.com

21%
OFF

Why Moderna Stock Just Crashed 21% - Nasdaq

2 weeks from now

2 days ago · CEO Stéphane Bancel said Moderna has cut its "cash operating cost by over 25 percent compared to 2023" and plans to make further cost cuts of $1 billion in 2025 and $500 …

nasdaq.com

$1
OFF

Moderna Stock Drops On Plans To Cut $1.1B In R&D Costs

2 weeks from now

Sep 12, 2024 · Key Takeaways Moderna shares fell Thursday morning after the COVID vaccine maker announced plans to trim its research and development pipeline to cut costs.The …

marketcap.com

$1
OFF

Moderna Stock Drops On Plans To Cut $1.1B In R&D Costs

2 weeks from now

Moderna CEO Stephane Bancel at the grand opening of the company's new headquarters outside Kendall Square on June 26, 2024. Moderna shares fell after announcing plans to trim its …

flipit.money

FAQs about Moderna Stock Drops on Plans To Cut $1.1B in R&D Costs - Yahoo … Coupon?

Will Moderna cut R&D spending by $1.1 billion?

Read the original article on Investopedia. Moderna shares fell Thursday morning as the COVID vaccine maker said it plans to cut R&D spending by $1.1 billion over the next three years. ...

How much will Moderna spend on R&D by 2027?

Moderna's plans include a $1.1 billion reduction in R&D expenses by 2027 to a range of $3.6 billion to $3.8 billion. Rather than spending to explore new products, the company will shift its focus to winning approvals for the 10 products in its pipeline. ...

Will Moderna cut costs in 2026?

The company also said it was speeding up and expanding a cost-cutting plan. It expects to cut cash costs by $1 billion in the new year, with additional cuts planned in 2026. Moderna pulled in most of its revenue last year from its COVID-19 vaccine, Spikevax, which brought in more than $3 billion in sales. ...

Why did Moderna stock fall 10% premarket?

Moderna (NASDAQ: MRNA) shares fell roughly 10% premarket on Thursday after the vaccine maker detailed plans to cut its annual R&D expense by $1.1B starting in 2027. The company is undertaking portfolio prioritization and cost efficiencies to reduce R&D expense by $1.1 billion, from $4.8 billion in 2024E to $3.6-3.8 billion in 2027. ...

Will Moderna slash its research and development budget in 2027?

Moderna said Thursday it plans to slash its research and development budget by $1.1 billion in 2027 as it focuses on launching 10 new products over the next three years. The company also issued light sales guidance for 2025 and pushed its break-even point out two years to 2028. ...

What will Moderna do to reduce costs by 2027?

The company said it will focus on getting FDA approval for 10 products to treat RSV and cancer, along with a combination COVID and flu vaccine. Moderna said it expects the moves to lower expenses by $1.1 billion by 2027. ...